Stock screener
Filter every US stock on the same numbers behind our pages, from P/E to insider buying. Or start from one of the ready-made ideas.
290 stocks
Prices and filings as of the close on Oct 30, 2026
| # | Company | Share price | 1D | Market cap | Yield | Payout ratio | FCF payout | Div. growth yrs | Div. 5Y | Sh. yield |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | $504.80 | −10.9% | $824B | – | – | – | – | – | 0.04% | |
| 2 | $406.97 | −0.96% | $365B | 2.2% | 57.3% | 34.3% | 16 | 12.6% | 2.5% | |
| 3 | $250.43 | −4.1% | $256B | – | – | – | – | – | 0.00% | |
| 4 | $306.08 | −7.3% | $108B | – | – | – | – | – | 0.63% | |
| 5 | $840.70 | −8.6% | $75.4B | – | – | – | – | – | 0.00% | |
| 6 | $52.15 | +1.9% | $57.4B | 2.1% | – | – | – | – | 3.5% | |
| 7 | $258.70 | −10.9% | $44.9B | – | – | – | – | – | 0.00% | |
| 8 | $274.37 | −7.4% | $42.9B | 0.19% | 5.8% | 7.8% | 0 | 3.7% | 1.0% | |
| 9 | $32.12 | +0.38% | $42.2B | – | – | – | – | – | 0.08% | |
| 10 | $191.31 | +0.55% | $41.0B | – | – | – | – | – | 0.00% | |
| 11 | $83.63 | −0.82% | $34.3B | 1.3% | 35.0% | – | 0 | – | 5.4% | |
| 12 | $54.73 | −7.4% | $32.7B | – | – | – | – | – | −7.0% | |
| 13 | $54.87 | −9.7% | $30.3B | 0.00% | – | – | 0 | – | 0.00% | |
| 14 | $36.91 | −1.6% | $26.7B | – | – | – | – | – | 0.00% | |
| 15 | $124.15 | −7.1% | $25.7B | – | – | – | – | – | 0.00% | |
| 16 | $73.47 | −1.8% | $24.8B | – | – | – | – | – | 0.00% | |
| 17 | $91.73 | −29.2% | $17.6B | – | – | – | – | – | 0.00% | |
| 18 | $343.12 | −1.6% | $16.4B | – | – | – | – | – | 1.8% | |
| 19 | $94.39 | −4.5% | $11.6B | 0.00% | – | – | 0 | – | 0.00% | |
| 20 | $21.65 | −3.0% | $11.5B | – | – | – | – | – | 0.00% | |
| 21 | $11.04 | −3.0% | $11.5B | – | – | – | – | – | −0.06% | |
| 22 | $57.50 | +1.2% | $11.2B | – | – | – | – | – | 0.00% | |
| 23 | $83.53 | −0.64% | $10.8B | – | – | – | – | – | 0.00% | |
| 24 | $77.02 | −1.2% | $10.6B | – | – | – | – | – | 0.00% | |
| 25 | $24.30 | −7.2% | $9.9B | – | – | – | – | – | 0.00% | |
| 26 | $332.29 | +2.4% | $9.8B | – | – | – | – | – | 0.00% | |
| 27 | $110.19 | −1.1% | $9.6B | 4.1% | – | – | 13 | 1.0% | 4.1% | |
| 28 | $56.15 | −4.8% | $9.4B | 0.61% | 32.1% | 20.9% | 4 | −31.9% | 2.2% | |
| 29 | $30.37 | −1.4% | $9.4B | – | – | – | – | – | 0.00% | |
| 30 | $61.18 | +5.3% | $9.4B | – | – | – | – | – | 1.9% | |
| 31 | $35.92 | +0.17% | $8.6B | 1.0% | 63.1% | 107% | 1 | – | −3.7% | |
| 32 | syreSpyre Therapeutics | $96.56 | −2.4% | $8.5B | – | – | – | – | – | 0.00% |
| 33 | $53.76 | −0.83% | $8.3B | 1.8% | – | – | 0 | 0.00% | 1.8% | |
| 34 | $28.52 | 0.00% | $8.3B | 1.2% | – | – | – | – | 1.2% | |
| 35 | $76.29 | −1.9% | $8.3B | 2.2% | – | – | 5 | 44.2% | 3.7% | |
| 36 | $41.00 | −1.3% | $7.9B | 5.9% | 118% | – | 16 | 2.7% | 4.0% | |
| 37 | $25.81 | −9.0% | $7.9B | – | – | – | – | – | 0.00% | |
| 38 | $23.38 | −1.7% | $7.7B | – | – | – | – | – | 0.00% | |
| 39 | $110.90 | −3.4% | $7.7B | 1.3% | 38.3% | 25.7% | 12 | 4.2% | 2.1% | |
| 40 | $47.81 | −3.8% | $7.6B | – | – | – | – | – | 0.00% | |
| 41 | $65.55 | +1.0% | $7.4B | – | – | 122% | – | – | −0.00% | |
| 42 | $59.40 | −10.6% | $7.3B | – | – | – | – | – | 0.00% | |
| 43 | $18.34 | −1.1% | $7.2B | 6.5% | – | – | 0 | – | 6.5% | |
| 44 | $24.34 | +0.12% | $6.9B | 2.8% | – | – | 0 | −15.2% | 2.8% | |
| 45 | $165.13 | −3.8% | $6.8B | – | – | – | – | – | 6.4% | |
| 46 | $26.10 | −2.0% | $6.8B | – | – | – | – | – | 0.00% | |
| 47 | $322.75 | +1.7% | $6.4B | – | – | – | – | – | 0.00% | |
| 48 | $96.87 | +0.23% | $6.4B | 0.00% | – | – | – | – | −0.10% | |
| 49 | $51.31 | +3.3% | $6.3B | 3.4% | 28.8% | 27.9% | 4 | 10.1% | 3.4% | |
| 50 | $16.00 | −11.7% | $6.3B | – | – | – | – | – | 0.00% |